of total expenses at 5.2%(y-o-y), the Net profit attributable to Equity holders of the Company in Q1/2019 were of Bt347.9 million which increased by Bt25.3 million or 7.8%(y-o-y), representing the Net
1: Overall Financial Performance Unit: mb Q1 18 % Q1 19 % Change % YoY Revenue 131.45 100.0% 132.54 100.0% 1.09 0.8% Cost 75.00 57.1% 73.41 55.4% (1.59) (2.1%) Gross Profit 56.45 42.9% 59.13 44.6
: Overall Financial Performance Unit: million baht Jan-Jun 2018 % Jan-Jun 2019 % Change % YoY Revenue 254.34 100.0% 273.96 100.0% 19.62 7.7% Cost 144.42 56.8% 147.42 53.8% 3.00 2.1% Gross Profit 109.92 43.2
, travelling aboard were not allowed. - The meeting with external parties in person were not allowed, conference call or online meeting was applied instead. - Approving to the change of appropriate working time
subsidiary as of March 31, 2020 was in the amount of 349.97 million baht, increased by 4.94 million baht or 1.43%. The change came from an increase in net profit from the Company’s performance of Quarter 1
the global lead price had continuously decreased. - Translation - 3 Net Profit For the 6-month period ending on 30 June 2019 – 2020, the Company’s net profits were THB 15.07 million and THB 15.36
EBITDA 612 1,062 Net Profit (Loss) (836) 990 HR C HRC Sales (k tons) 1,447 812 HRC Production Volume (k tons) 1,436 876 HRC Average Selling Price (THB./ton) 20,663 18,690 HRC Cash Margin (THB./Ton) 854
812 EBITDA 612 1,062 Net Profit (Loss) (836) 990 HR C HRC Sales (k tons) 1,447 812 HRC Production Volume (k tons) 1,436 876 HRC Average Selling Price (THB./ton) 20,663 18,690 HRC Cash Margin (THB./Ton
: Million Baht For the 3 months Change between QoQ Change between YoY For the 6 months Change between YoY Q2/17 Q1/17 Q2/16 Amount % Amount % Q2/17 Q2/16 Amount % Revenues from medical services 92.86 88.86